Non-invasive brain stimulation for pain reduction in patients with MS

Dr Maryam Zoghi

La Trobe University

November 2021

specialisation: Social And Applied Research

focus area: Better treatments

funding type: Incubator

project type: Investigator Led Research

Summary

Multiple sclerosis (MS) is a neurological disease that predominantly affects young adults. Pain can be a significant problem for a substantial proportion of people with MS. It can have a severe impact on activities of daily living and can be difficult to manage with medications.

The aim of this study is to assess the long-lasting effect of a non-invasive brain stimulation technique, transcranial direct current stimulation (tDCS), on pain reduction and improving the quality of life in people with MS. This treatment will be delivered with a battery-operated device which is very safe with very little side effects (e.g. mild itching sensation under one of the electrodes). The treatment involves applying mild electrical currents to specific regions of the brain to modulate pain perception. If this stimulation technique is effective in reducing pain for several weeks, it may provide a new option for pain relief and pain management in people with MS who experience pain.

Progress

Associate Professor Maryam Zoghi and her team have successfully recruited six participants for their clinical trial investigating the effectiveness of tDCS in alleviating pain among individuals diagnosed with MS. All participants have completed either 10 or 11 treatment sessions.

Early findings are encouraging – most participants reported a noticeable decrease in pain and anxiety, particularly after the treatment sessions. Positive changes in brain activity have also been observed.

Attendance and engagement in the treatment has been high, and the treatment has been delivered safely with no side effects reported. Participants found the treatment comfortable and manageable, and many have expressed an interest in continuing it in the future.

These findings suggest that tDCS may offer a promising, low-risk option for managing pain in people with MS, potentially enhancing their overall quality of life.

Associate Professor Zoghi and her team are continuing to analyse the data in more detail and plan to extend the study further.

A scientific publication is being prepared to highlight the preliminary results and insights gained so far and to engage with the broader research community.

Updated 31 March 2025 

lead investigator

total funding

$25,000

start year

2021

duration

4 years

STATUS

Current project

Stages of the research process

Fundamental laboratory Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline

10+ years

Translational Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline

5+ years

Clinical Studies and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline

3+ years

Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Non-invasive brain stimulation for pain reduction in patients with MS